#151860

Integrin AvB6 inhibiting Peptide

Please Enter Your Email ID
Email ID

Cat. #151860

Integrin AvB6 inhibiting Peptide

Cat. #: 151860

Sub-type: Inhibitor

Availability: Please enquire for quantities and pricing

Target: Integrin AvB6 inhibiting peptide

Function: Inhibitor

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: John Marshall

Institute: Queen Mary University of London

Tool Details
Handling
Target Details
References

Tool Details

*FOR RESEARCH USE ONLY

  • Tool name: Integrin AvB6 inhibiting Peptide
  • Research fields: Cancer;Cell biology
  • Tool sub type: Inhibitor
  • Source: HEK293
  • Target: Integrin AvB6 inhibiting peptide
  • Description: av?6 is a major new target for molecular-specific imaging and therapy of cancer. It is expressed only on epithelia and then usually only during processes of tissue remodelling; these include wound healing, chronic inflammation, and cancer. The av?6 inhibiting peptide could not only permit diagnostic imaging, but also to deliver anticancer therapy specifically to tumour cells while sparing local normal tissues.
  • Function: Inhibitor

Handling

  • Shipping conditions: Dry Ice

Target Details

  • Target: Integrin AvB6 inhibiting peptide

References

  • Saha et al. 2010. J Pathol. 222(1):52-63. PMID: 20629113.
  • High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.